GSK Plc (GSK)
47.03
-0.15
(-0.32%)
USD |
NYSE |
Oct 02, 16:00
47.02
-0.01
(-0.02%)
After-Hours: 20:00
GSK Gross Profit Margin (Quarterly) : 75.05% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 75.05% |
| March 31, 2026 | 75.12% |
| December 31, 2025 | 69.38% |
| September 30, 2025 | 73.80% |
| June 30, 2025 | 72.89% |
| March 31, 2025 | 74.37% |
| December 31, 2024 | 68.74% |
| September 30, 2024 | 70.94% |
| June 30, 2024 | 73.60% |
| March 31, 2024 | 73.69% |
| December 31, 2023 | 64.58% |
| September 30, 2023 | 72.22% |
| June 30, 2023 | 73.27% |
| March 31, 2023 | 72.55% |
| December 31, 2022 | 70.23% |
| September 30, 2022 | 69.19% |
| June 30, 2022 | 68.90% |
| March 31, 2022 | 62.59% |
| December 31, 2021 | 60.90% |
| September 30, 2021 | 70.27% |
| June 30, 2021 | 71.05% |
| March 31, 2021 | 67.03% |
| December 31, 2020 | 65.99% |
| September 30, 2020 | 68.52% |
| June 30, 2020 | 68.04% |
| Date | Value |
|---|---|
| March 31, 2020 | 68.03% |
| December 31, 2019 | 63.63% |
| September 30, 2019 | 66.57% |
| June 30, 2019 | 68.77% |
| March 31, 2019 | 68.78% |
| December 31, 2018 | 64.57% |
| September 30, 2018 | 67.42% |
| June 30, 2018 | 68.40% |
| March 31, 2018 | 66.89% |
| December 31, 2017 | 66.51% |
| September 30, 2017 | 66.19% |
| June 30, 2017 | 64.22% |
| March 31, 2017 | 65.97% |
| December 31, 2016 | 66.81% |
| September 30, 2016 | 66.38% |
| June 30, 2016 | 68.37% |
| March 31, 2016 | 66.61% |
| December 31, 2015 | 51.03% |
| September 30, 2015 | 66.28% |
| June 30, 2015 | 67.82% |
| March 31, 2015 | 66.61% |
| December 31, 2014 | 69.16% |
| September 30, 2014 | 68.97% |
| June 30, 2014 | 69.92% |
| March 31, 2014 | 69.62% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| AstraZeneca PLC | 76.09% |
| Johnson & Johnson | 68.73% |
| Eli Lilly & Co. | 85.78% |
| Merck & Co., Inc. | 71.51% |
| Novo Nordisk A/S | 78.21% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 32.74% |
| Return on Assets | 8.61% |
| Return on Invested Capital | 15.46% |
| Profit Margin (Quarterly) | 6.58% |
| Operating Margin (Quarterly) | 28.52% |
| Return on Net Operating Assets | 11.12% |